Professor, Internal Medicine, Ohio State University College of Medicine
Cardiology
Dr. Philip F. Binkley, MD
|
|
Give Review
Doctor Philip F. Binkley, MD is an expert in the field of Cardiology. He attended The Ohio State University College of Medicine. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Philip Binkley is also a published MD. He has 101 publication published. The most recent publication is: Increased ventricular contractility is not sufficient for effective positive inotropic intervention. Philip F. Binkley, MD is registered with Medicare and accepts Medicare payments.
Publications
- GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.
- A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive Heart failure exacerbation.
- The impact of insurance and socioeconomic status on outcomes for patients with left ventricular assist devices.
- βIV-Spectrin regulates TREK-1 membrane targeting in the Heart.
- Design and Implementation of a Randomized Controlled Trial of Genomic Counseling for Patients with Chronic Disease.
- Mentorship in an Academic Medical Center.
- Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.
- Evidence for the role of epstein barr virus infections in the pathogenesis of Acute coronary events.
- Effect of the approach to insulin therapy on glycaemic fluctuations and autonomic tone in hospitalized patients with diabetes.
- Molecular mechanisms underlying cardiac protein phosphatase 2A regulation in Heart.
- Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive Heart failure: demonstration in human subjects and verification in a paced can...
- Neurohumoral profile in congestive Heart failure: response to beta-blockade.
- Long-term indoramin therapy in congestive Heart failure: a double-blind, randomized, parallel placebo-controlled trial.
- Influence of flosequinan on autonomic tone in congestive Heart failure: implications for the mechanism of the positive chronotropic effect and survival influence of lo...
- Plasma endothelin correlates with the extent of pulmonary hypertension in patients with Chronic congestive heart failure.
- Histologic compaison of allograft myocardium between short- and long-term survivors of human cardiac transplantation.
- Augmentation of diastolic function with phosphodiesterase inhibition in congestive Heart failure.
- Hemodynamic-inotropic response to beta-blocker with intrinsic sympathomimetic activity in patients with congestive Cardiomyopathy.
- Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive Heart failure.
- PlA2, a variant of GPIIIa implicated in Coronary thromboembolic complications.
- Acute positive inotropic intervention: the catecholamines.
- Increased ventricular contractility is not sufficient for effective positive inotropic intervention.
- Dobutamine increases cardiac output of the total artificial Heart. Implications for vascular contribution of inotropic agents to augmented ventricular function.
- Dose- and time-dependent binding and kinetics of pindolol in patients with congestive Heart failure.
- The electrophysiologic effects of upright posture.
- Vascular hypertrophy is an early finding in essential Hypertension and is related to arterial pressure waveform contour.
- Role of spectral measures of heart rate variability as markers of Disease progression in patients with chronic congestive heart failure not treated with angiotensin-co...
- An echocardiographic and anatomic description of the donor-recipient Atrial anastomosis after orthotopic cardiac transplantation.
- Influence of an extracorporeal artificial ventricle on native ventricular performance.
- Differing autonomic response to dobutamine in the presence and absence of ischemia: implications for the autonomic contribution to positive inotropic intervention.
- Hemodynamic responses to indoramin at rest and during exercise in congestive Heart failure.
- Evaluation of Aortic distensibility with transesophageal echocardiography.
- Preliminary observations of Chronic indoramin therapy in congestive heart failure.
- Successful management of Acute myocarditis with biventricular assist devices and cardiac transplantation.
- Thermodilution measures of right ventricular ejection fraction and volumes in Heart transplant recipients: a comparison with radionuclide angiography.
- Enhanced ventricular ectopy following pindolol: an adverse effect of a beta blocker with intrinsic sympathomimetic activity.
- In vivo validation of the origin of the esophageal electrocardiogram.
- Effects of successful cardiac transplantation on plasma endothelin.
- Transesophageal echocardiographic assessment of the effects of age, gender, and hypertension on thoracic Aortic wall size, thickness, and stiffness.
- Echocardiographic evaluation of pulmonary Artery distensibility.
- Prospective study of the circadian pattern of blood pressure after Heart transplantation.
- Restoration of diurnal blood pressure variability after cardiac transplantation.
- Increased Aortic impedance precedes peripheral vasoconstriction at the early stage of ventricular failure in the paced canine model.
- Right ventricular Aneurysm: clinical and laboratory features.
- Clinical significance of terminal QRS abnormalities in the setting of inferior Myocardial infarction.
- Autonomic cardiac control. II. Noninvasive indices and basal response as revealed by autonomic blockades.
- Heart rate alternans.
- Effect of hypertonic saline solution on left ventricular afterload in normovolumic dogs.
- Autonomic cardiac control. III. Psychological stress and cardiac response in autonomic space as revealed by pharmacological blockades.
- Effects of physiologic and pharmacologic adrenergic stimulation on Heart rate variability.
- The anatomic relationship of the esophageal lead to the left atrium.
- The significance and prevention of air emboli with the total artificial Heart.
- Remnant Atrial function in human and animal recipients of a total artificial heart.
- Determination of pindolol in human plasma and urine by high-performance liquid chromatography with ultraviolet detection.
- Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning.
- Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
- Adenine nucleotide content in cold preserved human donor Hearts and subsequent cardiac performance after orthotopic Heart transplantation.
- Platypnea-orthodeoxia: an unusual indication for surgical closure of a patent foramen ovale.
- The role of beta receptors in the peripheral vasculature of calves with a total artificial Heart.
- Hypertonic saline is a negative inotropic agent in normovolumic dogs.
- Heart rate variability: two eras of investigation.
- Comparison of hypersensitivity to adrenergic stimulation after abrupt withdrawal of propranolol and nadolol: influence of half-life differences.
- The role of beta receptors in the peripheral vasculature in calves with a total artificial Heart.
- The equilibrium position of the mitral Valve: an accurate model of mitral Valve motion in humans.
- Nuggets, pearls, and vignettes of master Heart failure clinicians. Part 4--treatment.
- Pathophysiology of plaque instability: insights at the genomic level.
- Stem cell-derived cardiomyocytes demonstrate arrhythmic potential.
- The next era of examination and management of the patient with cardiovascular Disease.
- A polymorphism of the gene encoding AMPD1: clinical impact and proposed mechanisms in congestive Heart failure.
- A polymorphism of the endothelial nitric oxide synthase promoter is associated with an increase in autonomic imbalance in patients with congestive Heart failure.
- Psychological distress and cardiovascular Disease: results from the 2002 National Health Interview Survey.
- Depressive symptoms and inflammation among Heart failure patients.
- Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
- Sustained restoration of autonomic balance with long- but not short-acting metoprolol in patients with Heart failure.
- Navigating the crossroads of Coronary artery disease and heart failure.
- Highly variable mRNA expression and splicing of L-type voltage-dependent calcium channel alpha subunit 1C in human Heart tissues.
- Recovery of normal ventricular function in patients with dilated Cardiomyopathy: predictors of an increasingly prevalent clinical event.
- Endothelial nitric oxide synthase gene: prospects for treatment of heart Disease.
- Heart-specific ablation of Prkar1a causes failure of Heart development and myxomagenesis.
- Claudin-5 levels are reduced in human end-stage Cardiomyopathy.
- Latent development of occlusive Coronary atherosclerosis as a cause of decompensation of non-ischemic dilated cardiomyopathy.
- Regression of normalized left ventricular systolic function after discontinuation of treatment in patients with dilated Cardiomyopathy.
- Mind-body medicine in Chronic heart failure: a translational science challenge.
- Preface: depression and Heart failure.
- Screening and identification of depression among patients with Coronary heart disease and congestive heart failure.
- Myocardial viability and survival in ischemic left ventricular dysfunction.
- Selecting a mentor: a guide for residents, fellows, and young physicians.
- A new era in the natural history of dilated Cardiomyopathy.
- Relation of depression to severity of illness in Heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]).
- The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive Heart failure.
- Recurrence of Acute myocardial infarction in patients discharged on clopidogrel and a proton pump inhibitor after stent placement for Acute myocardial infarction.
- A promoter polymorphism of the endothelial nitric oxide synthase gene is associated with reduced mRNA and protein expression in failing human myocardium.
- Relationship between glycemic control and readmission rates in patients hospitalized with congestive Heart failure during implementation of hospital-wide initiatives.
- Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced ather...
- Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors.
- Safety and feasibility of autologous myoblast transplantation in patients with ischemic Cardiomyopathy: four-year follow-up.
- Feasibility and safety of autologous myoblast transplantation in patients with ischemic Cardiomyopathy.
- A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and Acute myeloid leukemia.
- Plasma atherogenic markers in congestive Heart failure and posttransplant (Heart) patients.
- The problem of ventricular dysrhythmias and sudden death mortality in Heart failure: the impact of current therapy.
Schools
Ohio State University College Of Medicine and Public Health
Ohio State University
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Ohio State University Hospital -
The Ohio State University College of Medicine
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1871533117 | |
| NPPES Provider LastName | BINKLEY | |
| NPPES Provider FirstName | PHILIP | |
| NPPES Provider ZIPCode | 432101240 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiology | |
| Total Claim Count | 641.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871533117 |
| Last Name Of The Provider | BINKLEY |
| First Name Of The Provider | PHILIP |
| View All |
Similar Doctors
|
Dr. Barry S. George, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan G. Weinberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harry Graber, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mukesh R. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ernest L. Mazzaferri Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ralph S. Augostini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lee Jordan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David L. Bicknell, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Dennis A. Calnon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sreedhar R. Billakanty, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ragavendra Baliga, MD
This Doctor is OpenDoctor Recommended.
|